Stuart Taylor is a Senior Scientist in Analytical Chemistry and Process Development at Purespring Therapeutics, specializing in HPLC methodologies for AAV gene therapy vectors and related impurities. With over 12 years of experience in the pharmaceutical industry, they have a strong background in method development and validation, having previously held roles at GSK and Gyroscope Therapeutics. Stuart has also contributed to regulatory submissions and collaborated on quality control for clinical materials. They earned a Bachelor of Science in Chemistry from The University of Sheffield, graduating in 2012.
This person is not in any offices